For the Inventor, By the Inventor

Enter assignee name

Rockville, MD, United States of America

Shire Laboratories, Inc.

USPTO Granted Patents = 25

% Expired Patents = 16.0

Trademarks = 3

Forward Citations = 1,654

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Beth A Burnside (22 out of 39 patents)

Edward M Rudnic (14 out of 48 patents)

Richard Alan Couch (11 out of 17 patents)

4. Charlotte M McGuinness (9 out of 9 patents)

5. Rong-Kun Chang (8 out of 24 patents)

6. Henry H Flanner (8 out of 25 patents)

7. Sandra E Wassink (7 out of 35 patents)

8. Xiaodi Guo (7 out of 8 patents)

9. Jill E Pinkett (6 out of 6 patents)

10. Amir H Shojaei (4 out of 4 patents)

11. John A McCarty (3 out of 22 patents)

12. Scott A Ibrahim (3 out of 3 patents)

13. Kimberly Fiske (3 out of 3 patents)

14. George W Belendiuk (2 out of 3 patents)

15. George W Belendiuk, Deceased (2 out of 2 patents)

Core Competencies:

Pulsed Dose

Osmotic Delivery

Sustained Release

Bioavailability

Formulations

Encapsulation

Pharmaceutical Compositions

Oral Dosage Forms

Stability

Fluidization

Acyclovir

Insulin

25 patents: Sort by Forward Citations

1. RE41148 - Oral pulsed dose drug delivery system (2010-02-22),

2. 7022337 - Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect (2006-04-04),

3. 7011846 - Oral capsule formulation with increased physical stability (2006-03-14),

4. 6913768 - Sustained release delivery of amphetamine salts (2005-07-05),

5. 6890918 - Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers (2005-05-10),

6. 6838093 - System for osmotic delivery of pharmaceutically active agents (2005-01-04),

7. 6814979 - Osmotic drug delivery system (2004-11-09),

8. 6811794 - Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles (2004-11-02),

9. 6793934 - Solid oral dosage form (2004-09-21),

10. 6772801 - Fluidization of particles for encapsulation in oral dosage pharmaceutical products (2004-08-10),

11. 6692767 - Solid solution beadlet (2004-02-17),

12. 6605300 - Oral pulsed dose drug delivery system (2003-08-12),

13. 6514532 - Soluble form osmotic dose delivery system (2003-02-04),

14. 6384020 - Rapid immediate release oral dosage form (2002-05-07),

15. 6361796 - Soluble form osmotic dose delivery system (2002-03-26),

Shire Laboratories, Inc., based in Rockville, MD, specializes in the development and manufacturing of innovative pharmaceutical products. The company focuses on addressing complex medical needs through advanced drug delivery systems and formulations. With a commitment to research and development, Shire aims to enhance patient outcomes by leveraging cutting-edge technologies in the biopharmaceutical sector. Its expertise spans various therapeutic areas, including rare diseases and specialty pharmaceuticals, contributing to improved healthcare solutions globally.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

25 Patents

#29 in Rockville, MD

#175 in Maryland

#13,350 in US

#25,681 in the World

Rockville, MD, United States of America

Shire Laboratories, Inc.

Forward Citations = 1,654

27 inventors:

Beth A Burnside (22 out of 39 patents)

Edward M Rudnic (14 out of 48 patents)

Richard Alan Couch (11 out of 17 patents)

4. Charlotte M McGuinness (9 out of 9 patents)

5. Rong-Kun Chang (8 out of 24 patents)

Please report any incorrect information to [email protected]

Loading…